Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
364.58
-21.61 (-5.60%)
At close: Aug 20, 2026, 4:00 PM EDT
387.30
+22.72 (6.23%)
Pre-market: Aug 21, 2026, 7:39 AM EDT
PRAX Market Cap
PRAX has a market cap or net worth of $10.18 billion as of August 21, 2026. Its market cap has increased by 979.73% in one year.
Market Cap
10.18B
Enterprise Value
8.81B
1-Year Change
979.73%
Ranking
Category
Stock Price
$364.58
ChartMarket Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $10.18B, an increase of 1,358.27%. That is a compound annual growth rate of 58.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 10.18B | 38.10% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 11.43B |
| Bio-Techne | 11.29B |
| Cytokinetics | 10.81B |
| Kymera Therapeutics | 10.59B |
| Summit Therapeutics | 10.46B |
| ABIVAX Société Anonyme | 10.38B |
| Krystal Biotech | 10.16B |
| Apogee Therapeutics | 10.16B |